PipelineReview.com - Target Pipelines

Show Cart

Target Pipelines

Results 71 - 80 of 80

Feb 2015 Competitor Analysis: Specific and Bispecific Her3 Antibodies

Jul 2013 Competitor Analysis ErbB / Her Receptor Antagonists

Jul 2013 Competitor Analysis: c-MET/HGF Inhibitors

May 2013 Competitor Analysis: Thrombolytics & Fibrinolytics

Apr 2013 Competitor Analysis: Insulin

Apr 2013 Competitor Analysis: Interferon

Apr 2013 Competitor Analysis: Thrombopoiesis Stimulating Agents (TPO and IL-11)

Apr 2013 Competitor Analysis: Human Growth Hormone (hGH)

Oct 2012 Competitor Analysis: Interleukin-6 (IL-6) Inhibitors and IL-6 Receptor (IL-6R) Antagonists

Jul 2012 Competitor Analysis: Interleukin-1 (IL-1) Inhibitors and IL-1 Receptor (IL-1R) Antagonists

Start
Prev
1
2
3
4
5
6
7
8
Next
End

Shopping cart

Cart empty

Latest report

PSMA-Targeted Therapy Pipeline Review

Featured Products

Claudin 18.2-Targeted Immunotherapy: a landscape analysis of stakeholders, drug modalities, pipeline and business opportunities from an industry perspective

CAR-M Industry Landscape Analysis: Chimeric Antigen Receptor-Macrophage (CAR-M) Stakeholders, Technologies, Pipeline, Partnering and Financing

RNA-Targeted Novel Drug Modalities Based on RNA Editing, Epitranscriptomics, Direct RNA Targeting, Splicing Modulation, Translation Regulation, lncRNA & regRNA Targeting & More: a landscape analysis of technologies, targets, business and financing from an industry perspective

Latest Target Pipeline

CD40 Agonists & CD40/L Antagonists Pipeline Review

Shopping cart

Cart empty

Latest report

PSMA-Targeted Therapy Pipeline Review

Featured Products

Claudin 18.2-Targeted Immunotherapy: a landscape analysis of stakeholders, drug modalities, pipeline and business opportunities from an industry perspective

CAR-M Industry Landscape Analysis: Chimeric Antigen Receptor-Macrophage (CAR-M) Stakeholders, Technologies, Pipeline, Partnering and Financing

RNA-Targeted Novel Drug Modalities Based on RNA Editing, Epitranscriptomics, Direct RNA Targeting, Splicing Modulation, Translation Regulation, lncRNA & regRNA Targeting & More: a landscape analysis of technologies, targets, business and financing from an industry perspective

Latest Target Pipeline

CD40 Agonists & CD40/L Antagonists Pipeline Review

La Merie Biologics

FREE Weekly News Bulletin

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing